Free Access
Nat. Sci. Soc.
Volume 13, Number 4, Octobre-Décembre 2005
Page(s) 371 - 382
Section Article
Published online 07 February 2006
  • Alves, A.P., Medina, N.H., Cruz, A.A., 2002. Trachoma and ethnic diversity in the upper Rio Negro Basin of Amazonas State, Brazil, Ophthal. Epidemiol., 9, 29-34. [CrossRef]
  • Amato, M.P., Battaglia, M.A., Caputo, D., Fattore, G., Gerzeli, S., Pitaro, M., Reggio, A., Trojano, M.; Mu.S.I.C. Study Group, 2002. The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy, J. Neurol., 249, 152-163. [CrossRef] [MathSciNet] [PubMed]
  • Anttila, T., Saikku, P., Koskela, P., Bloigu, A., Dillner, J., Ikaheimo, I., Jellum, E., Lehtinen, M., Lenner, P., Hakulinen, T., Narvanen, A., Pukkala, E., Thoresen, S., Youngman, L., Paavonen, J., 2001. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma, J. Am. Med. Assn., 285, 47-51. [CrossRef]
  • Balin, B.J., Gérard, H.C., Arking, E.J., Appelt, D.M., Branigan, P.J., Abrams, J.T., Whittum-Hudson, J.A., Hudson, A.P., 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain, Med. Microbiol. Immunol., 187, 23-42. [CrossRef] [PubMed]
  • Beeri, M.S., Werner, P., Adar, Z., Davidson, M., Noy, S., 2002. Economic cost of Alzheimer's disease in Israel, Alzheimer Dis. Assoc. Disord., 16, 73-80. [CrossRef] [PubMed]
  • Belland, R.J., Ouellette, S.P., Gieffers, J., Byrne, G.I., 2004. Chlamydia pneumoniae and atherosclerosis, Cell. Microbiol., 6, 117-127. [CrossRef]
  • Campbell, L.A., Kuo, C.C., 2004. Chlamydia pneumoniae – an infectious risk factor for atherosclerosis, Nat. Rev. Microbiol., 2, 23-32. [CrossRef]
  • Carter, J.D., Valeriano, J., Vasey, F.B., 2004. Doxycycline vs. doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison, J. Rheumatol., 31, 1973-1980. [PubMed]
  • CDC website: chlamydiapneumoniae
  • Centers for Disease Control and Prevention, 2004. Sexually transmitted disease surveillance 2003 supplement, Chlamydia prevalence monitoring project annual report 2003, Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention.
  • Chesson, H.W., Blandford, J.M., Gift, T.L., Tao, G., Irwin, K.L., 2004. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000, Perspect. Sex. Reprod. Health 36, 11-19. [CrossRef]
  • Ciervo, A., Petrucca, A., Cassone, A., 2003. Identification and quantification of Chlamydia pneumoniae in human atherosclerotic plaques by LightCycler real time PCR, Mol. Cell. Probes., 17, 107-111. [CrossRef]
  • Clementsen, P., Permin, H., Norn, S., 2002. Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease, J. Investigat. Allergol. Clin. Immunol., 12, 73-79.
  • Corsaro, D., Valassina, M., Venditti, D., 2003. Increasing diversity with Chlamydia, Crit. Rev. Microbiol., 29, 37-78. [CrossRef] [PubMed]
  • Corsaro, D., Venditti, D., 2004. Emerging chlamydial infections, Crit. Rev. Microbiol., 30, 75-106. [CrossRef] [PubMed]
  • Debattista, J., Martin, P., Jamieson, J., Crane, K., Dolton, I., Russell-Hall, S., DeSilva, J., Hargrave, R., Robinson, T., Ryan, N., Mortlock, M., 2002. Detection of Chlamydia trachomatis in an Australian high school student population, Sex. Transm. Dis., 78, 194-197. [CrossRef]
  • Fox, P.J., Kohatsu, N., Max, W., Arnsberger, P., 2001. Estimating the costs of caring for people Alzheimer's disease in California: 2000-2040, J. Publ. Health Policy, 22, 88-97. [CrossRef] [MathSciNet]
  • Frick, K.D., Arantxa-Colchero, M., Dean, D., 2004. Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis, Vaccine, 22, 690-697. [CrossRef]
  • Garbino, J., Sommer, R., Gerber, A., Regamey, C., Vernazza, P., Genne, D., Dur, P., Rothen, M., Unger, J.P., Lew, D., 2002. Prospective epidemiologic survey of patients with community acquired pneumonia requiring hospitalization in Switzerland, Int. J. Infect. Dis., 6, 288-293. [CrossRef] [PubMed]
  • Gérard, H.C., Branigan, P.J., Balsara, G.R., Heath, C., Minassian, S.S., Hudson, A.P., 1998. Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy, Fertil. Steril., 70, 945-948. [CrossRef] [PubMed]
  • Gerbase, A.C., Mertens, T.E., 1998. Sexually transmitted diseases in Africa: a time for action, Afr. Health, 20, 10-12. [PubMed]
  • Gerbase, A.C., Rowley, J.T., Heymann, D.H., Berkley, S.F., Piot, P., 1998. Global prevalence and incidence estimates of selected curable STDs, Sex. Transm. Infect., 74 (suppl. 1), S12-S16. [PubMed]
  • Grayston, J.T., 1992. Chlamydia pneumoniae, strain TWAR pneumonia, Annu. Rev. Med., 43, 317-323. [CrossRef] [PubMed]
  • Grayston, J.T., Kronmal, R.A., Jackson, L.A., Parisi, A.F., Muhlestein, J.B., Cohen, J.D., Rogers, W.J., Crouse, J.R., Borrowdale, S.L., Schron, E., Knirsch, C. for the ACES investigators, 2005. Azithromycin for the secondary prevention of coronary events, N. Engl. J. Med., 352, 1637-1645. [CrossRef] [PubMed]
  • Greub, G., Mege, J.-L., Raoult, D., 2003a. Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis, Infect. Immun., 71, 5979-5985. [CrossRef] [PubMed]
  • Erratum: 2004, Infect. Immun., 72, 621. [CrossRef]
  • Greub, G., Boyadjiev, I., LaScola B., Raoult, D., Martin C., 2003b. Serological hint suggesting that Parachlamydiaceae are agents of pneumonia in polytraumatized intensive care patients, Ann. N.Y. Acad. Sci., 990, 311-319. [CrossRef]
  • Grio, R., Latino, M.A., Leotta, E., Smirne, C., Lanza, A., Spagnolo, E., Perozziello, A., Caneparo, A., Bello, L., Lerro, R., 2004. Sexually transmitted diseases and pelvic inflammatory disease, Minerva Ginecol., 56, 141-147. [PubMed]
  • Groot, W., Van Den Brink, H.M., Plug, E., 2004. Money for health: the equivalent variation of cardiovascular diseases, Health Econ., 13, 850-872. [CrossRef]
  • Guaschino, S., De Seta, F./, 2000. Update on Chlamydia trachomatis, Ann. N.Y. Acad. Sci., 900, 293-300. [CrossRef]
  • Hahn, D.L., Azenabor, A.A., Beatty, W.L., Byrne, G.I., 2002. Chlamydia pneumoniae as a respiratory pathogen, Front. Biosci., 7, e66-e76. [CrossRef]
  • Hatch, T.P., 1999. Developmental biology, in Stephens, R.S. (Ed.), Chlamydia - Intracellular biology, Pathogenesis, and Immunity, Washington DC, ASM Press.
  • Heddema, E.R., Kraan, M.C., Buys-Bergen, H.E., Smith, H.E., Wertheim-van Dillem, P.M., 2003. A woman with a lobar infiltrate due to psittacosis detected by polymerase chain reaction, Scan. J. Infect. Dis., 35, 422-424. [CrossRef]
  • Hogan, R.J., Mathews, S.A., Mukjopadhyay, S., Summersgill, J.T., Timms, P., 2004. Chlamydial persistence: beyond the biphasic paradigm, Infect. Immun., 72, 1843-1855. [CrossRef] [PubMed]
  • Honey, E., Templeton, A., 2002. Prevention of pelvic inflammatory disease by control of C. trachomatis infection, Int. J. Gynaecol. Obstet., 78, 257-261. [CrossRef]
  • Hook, E.W., Peeling, R.W., 2004. Syphilis control – a continuing challenge, N. Engl. J. Med., 351, 122-124. [CrossRef] [PubMed]
  • Howell, M.R., Gaydos, J.C., McKee, K.T., Quinn, T.C., Gaydos, C.A., 1999. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease, Sex. Transm. Dis., 26, 519-526. [CrossRef] [PubMed]
  • Ito, I., Ishida, T., Mishima, M., Osawa, M., Arita, M., Hashimoto, T., Kishimoto, T., 2002. Familal cases of psittacosis: possible person-to-person transmission, Intern. Med., 41, 580-583. [CrossRef]
  • Johnsen, S., Birkebaek, N., Andersen, P.L., Emil C., Jensen J.S., Ostergaard, I., 2005. Indirect immunofluorescence and real time PCR for detection of Simkania negevensis in Danish adults with persistent cough and in healthy controls, Scand. J. Infect. Dis., 37, 251-255. [PubMed]
  • Joyee, A.G., Thyagarajan, S.P., Rajendran, P., Hari, R., Balakrishnan, P., Jeyaseelan, L., Kurien, T., and the STD Study Group, 2004. Chlamydia trachomatis genital infection in an apparently healthy adult population of Tamil Nadu, India: a population-based study, Int. J. STD AIDS, 15, 51-55. [CrossRef] [PubMed]
  • Kahane, S., Platzner, N., Dvoskin, B., Itzhaki, A., Friedman, M.G., 2004. Evidence for the presence of Simkania negevensis in drinking water and in reclaimed wastewater in Israel, Appl. Environ. Microbiol., 70, 3346-3351. [CrossRef] [PubMed]
  • Kalayoglu, M.V., Byrne, G.I., 1998a. Induction of macrophage foam cell formation by Chlamydia pneumoniae, J. Infect. Dis., 177, 172-179. [CrossRef]
  • Kalayoglu, M.V., Byrne, G.I., 1998b. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide, Infect. Immun., 66, 5067-5072. [PubMed]
  • Kasi, P.M., Gilani, A.I., 2004. Trachoma still ignored in developing countries, Lancet, 363, 1736 (letter). [CrossRef]
  • Keefover, R.W., 1996. The clinical epidemiology of Alzheimer's disease, Neurol. Clin., 14, 337-351. [CrossRef] [PubMed]
  • Kelly, A.M., Ireland, M., Aughey, D., 2004. Pelvic inflammatory disease in adolescents: high incidence and recurrence rates in an urban teen clinic, J. Pediatr. Adolesc. Gynecol., 17, 383-388. [CrossRef] [PubMed]
  • Krause, W., Bohring, C., 2003. Male infertility and genital chlamydial infection: victim or perpetrator?, Andrologia, 25, 209-216. [CrossRef]
  • Kumaresan, J.A., Mecaskey, J.W., 2003. The global elimination of trachoma: progress and promise, Am. J. Trop. Med. Hyg., 69(5 suppl.), 24-28. [NASA ADS] [CrossRef] [PubMed]
  • LaMontagne, D.S., Fenton, K.A., Randall, S., Anderson, S., Carter, P. 2004. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening, Sex. Transm. Infect., 80, 335-341. [CrossRef] [PubMed]
  • Leinonen, M., 1993. Pathogenic mechanisms and epidemiology of Chlamydia pneumoniae, Eur. Heart J., 14 (suppl. K), 57-61. [CrossRef]
  • Lin, T.M., Kuo, C.C., Chen, W.J., Lin, F.J., Eng, H.L., 2004. Seroprevalence of Chlamydia pneumoniae infection in Taiwan, J. Infect. Dis., 48, 91-95. [NASA ADS] [CrossRef] [PubMed]
  • Loeb, M.B., Molloy, D.W., Smieja, M., Standish, T., Goldsmith, C.H., Mahony, J., Smith, S., Borrie, M., Decoteau, E., Davidson, W., McDougall, A., Gnarpe, J., O'Donnell, M., Chernesky, M., 2004. A randomized controlled trial of doxycycline and rifampin for patients with Alzheimer's disease, J. Am. Geriatr. Soc., 52, 381-387. [CrossRef] [PubMed]
  • Longbottom, D., 2003. Chlamydial vaccine development, J. Med. Microbiol., 52, 537-540. [CrossRef] [PubMed]
  • Mabey, D.C., Solomon, A.W., Foster, A., 2003. Trachoma, Lancet, 362, 223-229. [CrossRef] [PubMed]
  • Mårdh, P.-A., 2004a. Tubal factor infertility, with special regard to chlamydial salpingitis, Curr. Opin. Infect. Dis., 17, 49-52. [CrossRef] [PubMed]
  • Mårdh, P.-A., 2004b. Surveillance – what we know and do not know about the spread of infections by Chlamydia trachomatis, in Deák, J. (Ed.), Proceedings of the Fifth Meeting of the European Society for Chlamydia Research, Budapest (Hungary), Pauker Nyomdaipari Kft.
  • Marrie, T.J., Peeling, R.W., Reid, T., DeCarolis, E.; Canadian Community Acquited Pneumonia Investigators, 2003. Chlamydia species as a cause of community acquired pneumonia in Canada, Eur. Respir. J., 21, 779-784. [CrossRef]
  • Masata, J., Drazdaková, M., Hruba, D., Rezacova, J., 2004. Prevalence of genital chlamydial infections among young females in Prague, in Deák, J. (Ed.) Proceedings of the Fifth Meeting of the European Society for Chlamydia Research, Budapest (Hungary), Pauker Nyomdaipari Kft.
  • Maza, L.M. de la, Peterson, E.M., 2002. Vaccines for Chlamydia trachomatis infections, Curr. Opin. Investig. Drugs, 3, 980-986. [PubMed]
  • Michelow, I.C., Olsen, K., Lozano, J., Rollis, N.K., Duffy, L.B., Ziegler, T., Kauppila, J., Leinonen, M., McCracken, G.H., 2004. Epidemiology and clinical characteristics of community acquired pneumonia in hospitalized children, Pediatrics, 113, 701-707. [CrossRef]
  • Miranda, A.E., Szwarcwald, C.L., Peres, R.L., Page-Shafer, K., 2004. Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil, Sex. Transm. Dis., 31, 542-546. [CrossRef] [PubMed]
  • Moazed, T.C., Kuo, C.C., Grayston, J.T., Campbell, L.A., 1998. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse, J. Infect. Dis., 177, 1322-1325. [CrossRef] [PubMed]
  • Molano, M., Weiderpass, E., Posso, H., Morre, S.A., Ronderos, M., Franceschi, S., Arslan, A., Meijer, C.J., Monoz, N., van den Brule, A.J., and the HPV Study Group, 2003. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Columbia, Sex. Transm. Infect., 79, 474-478. [CrossRef] [PubMed]
  • Moxon, R., Rappuoli, R., 2002. Bacterial pathogen genomics and vaccines, Br. Med. Bull., 62, 45-58. [CrossRef] [PubMed]
  • Nusbaum, M.R., Wallace, R.R., Slatt, L.M., Dondrad, E.C., 2004. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus, J. Am. Osteopath. Assn., 104, 527-535.
  • Parish, W.L., Laumann, E.O., Cohen, M.S., Pan, S., Zheng, H., Hoffman, I., Wang, T., Ng, K.H., 2003. Population-based study of chlamydial infection in China: a hidden epidemic, J. Am. Med. Assn., 289, 1265-1273. [CrossRef]
  • Powell, J., O'Connor, C., O'hlarlaithe, M., Saunders, J., DeFreitas, J., 2004. Chlamydia trachomatis prevalence in men in the mid-west of Ireland, Sex. Transm. Infect., 80, 349-353. [CrossRef] [PubMed]
  • Ragonese, P., Salemi, G., D'Amelio, M., Gammino, M., Aridon, P., Savettieri, G., 2004. Multiple sclerosis in southern Europe : Monreale City, Italy. A twenty year follow-up incidence and prevalence study, Neuroepidemiology, 23, 306-309. [CrossRef] [PubMed]
  • Rich, E., Hook, E.W., Alarcon, G.S., Moreland, L.W., 1996. Reactive arthritis in patients attending an urban sexually transmitted disease clinic, Arthritis Rheum., 39, 1172-1177. [CrossRef] [PubMed]
  • Rigaud, A.-S., Fagnani, F., Bayle, C., Latour, F., Traykov, L., Forette, F., 2003. Patients with Alzheimer's disease living at home in France: costs and consequences of the disease, J. Geriatr. Psychiatry Neurol., 16, 140-145. [CrossRef] [PubMed]
  • Saikku, P., Leinonen, M., Mattila, K., Ekman, M.R., Nieminen, M.S., Makela, P.H., Huttunen, J.K., Valtonen, V., 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet, 2, 983-986. [CrossRef] [PubMed]
  • Sarasoja, T., Wikstrom, J., Paltamaa, J., Hakama, M., Sumelahti, M.L., 2004. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years, Acta Neurol. Scand., 110, 331-336. [CrossRef] [PubMed]
  • Schachter, J., 1999. Infection and disease epidemiology, in Stephens, R.S. (Ed.), Chlamydia: Intracellular Biology, Pathogenesis, and Immunity, Washington DC, ASM Press.
  • Schmidt, S.M., Muller, C.E., Krechting, M., Wiersbitzky, H., Gurtler, L., Wiersbitzky, S.K., 2003. Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases, Infection, 31, 410-416. [NASA ADS] [CrossRef] [PubMed]
  • Shimizu, C., Nabeshima, S., Kikuchi, K., Furusyo, N., Kashiwagi, S., Hayashi, J., 2002. Prevalence of antibody to Chlamydia pneumoniae in residents of Japan, the Solomon Islands, and Nepal, Am. J. Trop. Med. Hyg., 67, 170-175. [PubMed]
  • Smith, K.A., Bradley, K.K., Stobierski, M.G., Tengelsen, L.A., National Association of State Public Health Veterinarians Psittacosis Compendium Committee, 2005. Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds, J. Am Vet. Med. Assoc., 226, 532-539. [CrossRef]
  • Soderlin, M.K., Borjesson, O., Kautianen, H., Skogh, T., Leirisalo-Repo, M., 2002. Annual incidence of inflammatory joint diseases in a population based in southern Sweden, Ann. Rheum. Dis., 61, 911-915. [CrossRef] [PubMed]
  • Sriram, S., Stratton, C.W., Yao, S., Tharp, A., Ding, L., Bannan, J.D., Mitchell, W.M., 1999. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis, Ann. Neurol., 46, 6-14. [CrossRef] [PubMed]
  • Swanborg, R.H., Whittum-Hudson, J.A., Hudson, A.P., 2003. Infectious agents and multiple sclerosis – are human herpes virus 6 and Chlamydia pneumoniae involved?, J. Neuroimmunol., 136, 1-8. [CrossRef] [PubMed]
  • Taylor, H.R., 2001. Trachoma in Australia, Med. J. Aust., 175, 371-372. [PubMed]
  • Telfer, B.L., Moberley, S.A., Hort, K.P., Branley, J.M., Dwyer, D.E., Muscatello, D.J., Correll, PlK., England, J., McAunlty, J.M., 2005. Probable psittacosis outbreak linked to wild birds, Emerg. Infect. Dis., 11, 391-397. [CrossRef] [PubMed]
  • Tobin, J.M., Harindra, V., Mani, R., 2004. Which treatment for genital tract Chlamydia trachomatis infection?, Int. J. STD AIDS, 15, 737-739. [CrossRef] [PubMed]
  • Villareal, C., Whittum-Hudson, J.A., Hudson, A.P., 2002. Persistent Chlamydiae and chronic arthritis, Arthritis Res., 4, 5-9. [CrossRef] [PubMed]
  • Ward, M.E., 1999. Mechanisms of Chlamydia-induced pathogenesis, in Stephens, R.S. (Ed.), Chlamydia - Intracellular biology, Pathogenesis, and Immunity, Washington DC, ASM Press.
  • Watts, S., 1997. Epidemics and History, Disease, Power, and Imperialism, New Haven, Ct, Yale University Press.
  • West, S.K., 2004. Trachoma: new assault on an ancient disease, Prog. Ret. Eye Res., 23, 381-401. [CrossRef]
  • Whittum-Hudson, J.A., 1999. Prevention vs. treatment of Chlamydial infections: A novel experimental approach, Curr. Treatment Options Infect. Dis., 1, 88-92.
  • Whittum-Hudson, J.A., 2005. Ocular chlamydial infections, in Zierhut, M., Stern, M.E., Sullivan, D.A. (Eds), Immunology of the Lacrimal Gland, Tear Film and Ocular Surface, London, Taylor and Francis.
  • Whittum-Hudson, J.A., An, L.-L., MacDonald, A.B., Prendergast, R.A., Saltzman, W.M., 1996. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection, Nat. Med., 2, 1116-1121. [CrossRef] [PubMed]
  • Whittum-Hudson, J.A., Rudy, D., Gerard, H., Vora, G., Davis, E., Haller, P.K., Prattis, S.M., Hudson, A.P., Saltzman, W.M., Stuart, E.S., 2001. The anti-Idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis, Vaccine, 19, 4061-4071. [CrossRef] [PubMed]
  • Whittum-Hudson, J.A., Gérard, H.C., Schumacher, H.R., Hudson, A.P., 2004. Chlamydiae and inflammatory arthritis, in Columbus, F. (Ed.), Focus on Arthritis Research, Nova Science Publishers Inc., 175-199.
  • Whittum-Hudson, J.A., Gérard, H.C., Schumacher, H.R., Hudson, A.P., 2005a. Pathogenesis of Chlamydia-associated arthritis, in Bavoil, P., Wyrick, P. (Eds), Chlamydia – Pathogenesis and Treatments, Blackwell Publishing, Inc. In press.
  • Whittum-Hudson, J.A., Schumacher, H.R., Hudson, A.P., 2005b. Chlamydia pneumoniae and inflammatory arthritis, in Yamamoto, Y., Friedman, H., Bendinelli, M. (Eds), Chlamydia pneumoniae Infection and Diseases, New York, Kluwer/Academic Press, 227-238.
  • Yamaguchi, T., Yamazaki, T., Inoue, M., Mashida, C., Kawagoe, K., Ogawa, M., Shiga, S., Nakagawa, Y., Kishimoto, T., Kurane, I., Ouchi, K., Ohzeki, T., 2005. Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test, FEMS Immunol. Med. Microbiol., 43, 21-27. [CrossRef] [MathSciNet] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.